American Journal of Neuroradiology, Vol 17, Issue 5 965-972, Copyright © 1996 by American Society of Neuroradiology
ARTICLES |
The spectrum of brain MR abnormalities in sickle-cell disease: a report from the Cooperative Study of Sickle Cell Disease
FG Moser, ST Miller, JA Bello, CH Pegelow, RA Zimmerman, WC Wang, K Ohene- Frempong, A Schwartz, EP Vichinsky, D Gallagher and TR Kinney
Department of Imaging, Cedars-Sinai Medical Center, Los Angeles, Calif 90048, USA.
PURPOSE: To define the spectrum of abnormalities in sickle-cell disease, including infarction, atrophy, and hemorrhage, that are identified by brain MR imaging. METHODS: All MR studies included T1, T2, and intermediate pulse sequences. Images were interpreted without knowledge of the clinical history or neurologic examination findings. Brain MR imaging was performed in 312 children with sickle-cell disease. RESULTS: Seventy patients (22%) had infarction/ischemia and/or atrophy, infarction/ischemia was noted in 39 children (13%) who had no history of a stroke (the "silent" group). The prevalence rates for silent lesions were 17% for sickle-cell anemia and 3% for hemoglobin sickle-cell disease. For patients with sickle-cell anemia and a history of cerebrovascular accident, infarction/ischemia lesions typically involved both cortex and deep white matter, while silent lesions usually were confined to deep white matter. Within the age range studied, the prevalence of infarction/ischemia did not increase significantly with age, although older patients with lesions had more lesions than did younger patients with lesions. CONCLUSIONS: Brain MR imaging showed infarction/ischemia in the absence of a recognized cerebrovascular accident in 13% of patients. The prevalence of these lesions did not increase significantly between the ages of 6 and 14 years, suggesting that lesions are present by age 6. However, the increase in the average number of lesions per patient with age may indicate progressive brain injury.
This article has been cited by other articles:
![]() |
G. S. Silva, P. Vicari, M. S. Figueiredo, H. Carrete Junior, M. H. Idagawa, and A. R. Massaro Brain Magnetic Resonance Imaging Abnormalities in Adult Patients With Sickle Cell Disease: Correlation With Transcranial Doppler Findings Stroke, July 1, 2009; 40(7): 2408 - 2412. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Roach, M. R. Golomb, R. Adams, J. Biller, S. Daniels, G. deVeber, D. Ferriero, B. V. Jones, F. J. Kirkham, R. M. Scott, et al. Management of Stroke in Infants and Children: A Scientific Statement From a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young Stroke, September 1, 2008; 39(9): 2644 - 2691. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Schatz, C. B. McClellan, E. S. Puffer, K. Johnson, and C. W. Roberts Neurodevelopmental Screening in Toddlers and Early Preschoolers With Sickle Cell Disease J Child Neurol, January 1, 2008; 23(1): 44 - 50. [Abstract] [PDF] |
||||
![]() |
M. C. Kral, R. T. Brown, J. K. Cure, N. Besenski, S. M. Jackson, and M. R. Abboud Radiographic Predictors of Neurocognitive Functioning in Pediatric Sickle Cell Disease J Child Neurol, January 1, 2006; 21(1): 37 - 44. [Abstract] [PDF] |
||||
![]() |
O. S. Platt Prevention and Management of Stroke in Sickle Cell Anemia Hematology, January 1, 2006; 2006(1): 54 - 57. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Hankins, R. E. Ware, Z. R. Rogers, L. W. Wynn, P. A. Lane, J. P. Scott, and W. C. Wang Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study Blood, October 1, 2005; 106(7): 2269 - 2275. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Kral and R. T. Brown Transcranial Doppler Ultrasonography and Executive Dysfunction in Children with Sickle Cell Disease J. Pediatr. Psychol., April 1, 2004; 29(3): 185 - 195. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hoppe, W. Klitz, S. Cheng, R. Apple, L. Steiner, L. Robles, T. Girard, E. Vichinsky, and L. Styles Gene interactions and stroke risk in children with sickle cell anemia Blood, March 15, 2004; 103(6): 2391 - 2396. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Grueneich, M. D. Ris, W. Ball, K. A. Kalinyak, R. Noll, K. Vannatta, and R. Wells Relationship of Structural Magnetic Resonance Imaging, Magnetic Resonance Perfusion, and Other Disease Factors to Neuropsychological Outcome in Sickle Cell Disease J. Pediatr. Psychol., March 1, 2004; 29(2): 83 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Henry, M. C. Driscoll, M. Miller, T. Chang, and C. P. Minniti Pseudotumor Cerebri in Children With Sickle Cell Disease: A Case Series Pediatrics, March 1, 2004; 113(3): e265 - 269. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Buchanan, M. R. DeBaun, C. T. Quinn, and M. H. Steinberg Sickle Cell Disease Hematology, January 1, 2004; 2004(1): 35 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Claster and E. P Vichinsky Managing sickle cell disease BMJ, November 15, 2003; 327(7424): 1151 - 1155. [Full Text] [PDF] |
||||
![]() |
S. T. Miller, S. P. Rao, J. H. Boyd, and M. R. DeBaun Acute chest syndrome, transfusion, and neurologic events in children with sickle cell disease Blood, August 15, 2003; 102(4): 1556 - 1557. [Full Text] [PDF] |
||||
![]() |
M. C. Kral, R. T. Brown, P. J. Nietert, M. R. Abboud, S. M. Jackson, and G. W. Hynd Transcranial Doppler Ultrasonography and Neurocognitive Functioning in Children With Sickle Cell Disease Pediatrics, August 1, 2003; 112(2): 324 - 331. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Steen, G. M. Hankins, X. Xiong, W. C. Wang, K. Beil, J. W. Langston, and K. J. Helton Prospective Brain Imaging Evaluation of Children with Sickle Cell Trait: Initial Observations Radiology, July 1, 2003; 228(1): 208 - 215. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Steen, T. Emudianughe, G. M. Hankins, L. W. Wynn, W. C. Wang, X. Xiong, and K. J. Helton Brain Imaging Findings in Pediatric Patients with Sickle Cell Disease Radiology, July 1, 2003; 228(1): 216 - 225. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Oguz, X. Golay, F. B. Pizzini, C. A. Freer, N. Winrow, R. Ichord, J. F. Casella, P. C. M. van Zijl, and E. R. Melhem Sickle Cell Disease: Continuous Arterial Spin-labeling Perfusion MR Imaging in Children Radiology, May 1, 2003; 227(2): 567 - 574. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hoppe, W. Klitz, J. Noble, L. Vigil, E. Vichinsky, and L. Styles Distinct HLA associations by stroke subtype in children with sickle cell anemia Blood, April 1, 2003; 101(7): 2865 - 2869. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Driscoll, A. Hurlet, L. Styles, V. McKie, B. Files, N. Olivieri, C. Pegelow, B. Berman, R. Drachtman, K. Patel, et al. Stroke risk in siblings with sickle cell anemia Blood, March 15, 2003; 101(6): 2401 - 2404. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kellinghaus, E. Montgomery, S. Neme, P. Ruggieri, and H. O. Luders Unilateral absence of the basal ganglia plus epilepsy without motor symptoms Neurology, March 11, 2003; 60(5): 870 - 873. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Steen, M. A. Miles, K. J. Helton, S. Strawn, W. Wang, X. Xiong, and R. K. Mulhern Cognitive Impairment in Children with Hemoglobin SS Sickle Cell Disease: Relationship to MR Imaging Findings and Hematocrit AJNR Am. J. Neuroradiol., March 1, 2003; 24(3): 382 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Thompson Jr., F. D. Armstrong, C. L. Link, C. H. Pegelow, F. Moser, and W. C. Wang A Prospective Study of the Relationship Over Time of Behavior Problems, Intellectual Functioning, and Family Functioning in Children With Sickle Cell Disease: A Report From the Cooperative Study of Sickle Cell Disease J. Pediatr. Psychol., January 1, 2003; 28(1): 59 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Schatz, D. A. White, A. Moinuddin, M. Armstrong, and M. R. DeBaun Lesion Burden and Cognitive Morbidity in Children With Sickle Cell Disease J Child Neurol, December 1, 2002; 17(12): 890 - 894. [Abstract] [PDF] |
||||
![]() |
K. J. Helton, W. C. Wang, L. W. Wynn, R. B. Khan, and R. G. Steen The Effect of Hydroxyurea on Vasculopathy in a Child with Sickle Cell Disease AJNR Am. J. Neuroradiol., November 1, 2002; 23(10): 1692 - 1696. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Pegelow, E. A. Macklin, F. G. Moser, W. C. Wang, J. A. Bello, S. T. Miller, E. P. Vichinsky, M. R. DeBaun, L. Guarini, R. A. Zimmerman, et al. Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease Blood, April 15, 2002; 99(8): 3014 - 3018. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Grant Steen, X. J. Hu, V. E. Elliott, M. A. Miles, S. Jones, and W. C. Wang Kindergarten Readiness Skills in Children With Sickle Cell Disease: Evidence of Early Neurocognitive Damage? J Child Neurol, February 1, 2002; 17(2): 111 - 116. [Abstract] [PDF] |
||||
![]() |
C. H. Pegelow, W. Wang, S. Granger, L. L. Hsu, E. Vichinsky, F. G. Moser, J. Bello, R. A. Zimmerman, R. J. Adams, D. Brambilla, et al. Silent Infarcts in Children With Sickle Cell Anemia and Abnormal Cerebral Artery Velocity Arch Neurol, December 1, 2001; 58(12): 2017 - 2021. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Wandersee, J. C. Lee, S. A. Deveau, and J. E. Barker Reduced incidence of thrombosis in mice with hereditary spherocytosis following neonatal treatment with normal hematopoietic cells Blood, June 15, 2001; 97(12): 3972 - 3975. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Malouf Jr, J. E. Hamrick-Turner, M. C. Doherty, G. S. Dhillon, R. V. Iyer, and M. G. Smith Implementation of the STOP Protocol for Stroke Prevention in Sickle Cell Anemia by Using Duplex Power Doppler Imaging Radiology, May 1, 2001; 219(2): 359 - 365. [Abstract] [Full Text] |
||||
![]() |
R. J. Adams Stroke Prevention and Treatment in Sickle Cell Disease Arch Neurol, April 1, 2001; 58(4): 565 - 568. [Full Text] [PDF] |
||||
![]() |
R. J. Adams, K. Ohene-Frempong, and W. Wang Sickle Cell and the Brain Hematology, January 1, 2001; 2001(1): 31 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Styles, C. Hoppe, W. Klitz, E. Vichinsky, B. Lubin, and E. Trachtenberg Evidence for HLA-related susceptibility for stroke in children with sickle cell disease Blood, June 1, 2000; 95(11): 3562 - 3567. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bernaudin, S. Verlhac, F. Freard, F. Roudot-Thoraval, M. Benkerrou, I. Thuret, R. Mardini, J.P. Vannier, E. Ploix, M. Romero, et al. Multicenter Prospective Study of Children With Sickle Cell Disease: Radiographic and Psychometric Correlation J Child Neurol, May 1, 2000; 15(5): 333 - 343. [Abstract] [PDF] |
||||
![]() |
S. T. Miller, L. A. Sleeper, C. H. Pegelow, L. E. Enos, W. C. Wang, S. J. Weiner, D. L. Wethers, J. Smith, and T. R. Kinney Prediction of Adverse Outcomes in Children with Sickle Cell Disease N. Engl. J. Med., January 13, 2000; 342(2): 83 - 89. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Kinney, L. A. Sleeper, W. C. Wang, R. A. Zimmerman, C. H. Pegelow, K. Ohene-Frempong, D. L. Wethers, J. A. Bello, E. P. Vichinsky, F. G. Moser, et al. Silent Cerebral Infarcts in Sickle Cell Anemia: A Risk Factor Analysis Pediatrics, March 1, 1999; 103(3): 640 - 645. [Abstract] [Full Text] |
||||
![]() |
D. R. Powars, P. S. Conti, W.-Y. Wong, P. Groncy, C. Hyman, E. Smith, N. Ewing, R. N. Keenan, C.-S. Zee, Y. Harold, et al. Cerebral Vasculopathy in Sickle Cell Anemia: Diagnostic Contribution of Positron Emission Tomography Blood, January 1, 1999; 93(1): 71 - 79. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Adams, V. C. McKie, L. Hsu, B. Files, E. Vichinsky, C. Pegelow, M. Abboud, D. Gallagher, A. Kutlar, F. T. Nichols, et al. Prevention of a First Stroke by Transfusions in Children with Sickle Cell Anemia and Abnormal Results on Transcranial Doppler Ultrasonography N. Engl. J. Med., July 2, 1998; 339(1): 5 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ohene-Frempong, S. J. Weiner, L. A. Sleeper, S. T. Miller, S. Embury, J. W. Moohr, D. L. Wethers, C. H. Pegelow, F. M. Gill, and t. C. S. o. Sickle Cell Disease Cerebrovascular Accidents in Sickle Cell Disease: Rates and Risk Factors Blood, January 1, 1998; 91(1): 288 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Hankins, R. E. Ware, Z. R. Rogers, L. W. Wynn, P. A. Lane, J. P. Scott, and W. C. Wang Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study Blood, October 1, 2005; 106(7): 2269 - 2275. [Abstract] [Full Text] [PDF] |
||||











